Colgate-Palmolive Company
Colgate-Palmolive sells oral care, toothpaste and toothbrushes, and, at Hill's, pet nutrition through the veterinary channel. The toothpaste tube is a product people buy again. It is not the only one: Procter & Gamble competes with Crest, and private label takes shelf space. In pet food, Purina and Mars cover another part of the aisle. Hill's is not the whole pet market.
Much of the selling is done outside the United States, so the exchange rate moves dollar profit. Packaging and input costs move the margin too. Toothpaste demand is habitual. It is not inelastic by decree. This report does not state a global share and does not call the business crisis-proof.
The dividend has been in the accounts for many years. This report does not count the decades and does not treat the raise as assured. It has to fit in the year's cash.
"The advantage is the tube the shopper already recognises and the vet who already recommends Hill's. Crest and private label contest the shelf. The moat narrows if the price rises and volume moves to private label, or if the exchange rate eats profit earned abroad."
Loading the Vaultflake…
—
Health is debt against a branded business, not a cyclical factory. Quality is the margin after product cost and currency. Toothpaste growth is slow; Hill's is the leg that can move more. P/E is read against a favourable-currency year, not against that year as if it were normal. Shareholder return is the dividend, checked against cash. Do not call it a closed streak.
The P/E of a weak-dollar year is not constant-currency earnings. EV/EBITDA is read without treating the brand as an asset that does not depreciate when rivals compete. Do not use Procter's multiple as if toothpaste and detergent were the same book. A dash if the CL cache is cold.
Not advice on CL. Vaultflake does not split oral care and Hill's and does not certify a dividend streak. This is not a 40% share. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
The advantage is the tube the shopper already recognises and the vet who already recommends Hill's. Crest and private label contest the shelf. The moat narrows if the price rises and volume moves to private label, or if the exchange rate eats profit earned abroad.
Health is debt against a branded business, not a cyclical factory. Quality is the margin after product cost and currency. Toothpaste growth is slow; Hill's is the leg that can move more. P/E is read against a favourable-currency year, not against that year as if it were normal. Shareholder return is the dividend, checked against cash. Do not call it a closed streak.
The P/E of a weak-dollar year is not constant-currency earnings. EV/EBITDA is read without treating the brand as an asset that does not depreciate when rivals compete. Do not use Procter's multiple as if toothpaste and detergent were the same book. A dash if the CL cache is cold.
Not advice on CL. Vaultflake does not split oral care and Hill's and does not certify a dividend streak. This is not a 40% share. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.
Consumer Staples · Beverages
Consumer Staples · Household Products
Consumer Staples · Food and Beverages
Consumer Staples · Supermarkets
Consumer Staples · Snacks and Beverages
Consumer Staples · Membership Warehouses
A free account opens the interactive chart. The Vault assistant is Premium.